Relay Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Relay Therapeutics

04/05/2023 22:39

* Relay Therapeutics Inc  RLAY.OQ  reported a quarterly
adjusted
loss of 78 cents​​ per share for the quarter ended in March. The
mean expectation of eleven analysts for the quarter was for a
loss of 69 cents per share.
    * Revenue fell 46.1% to $226.00 thousand from a year ago;
analysts
expected $188.00 thousand. 
    * Relay Therapeutics Inc's reported EPS for the quarter was
a loss
of 78 cents​.
    * The mean earnings estimate of analysts had risen by
about 7.1%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * Relay Therapeutics Inc shares had fallen by 31.9% this
quarter and lost 25.0% so far this year.
    * The company reported a quarterly loss of $94.24 million.
    * Wall Street's median 12-month price target for Relay
Therapeutics Inc is $29.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
4 at 09:39 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.69          -0.78          Missed
 Dec. 31 2022      -0.70          -0.56          Beat
 Sep. 30 2022      -0.71          -0.76          Missed
 Jun. 30 2022      -0.63          -0.71          Missed